Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects A double blind test
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 72 (2-3), 205-211
- https://doi.org/10.1016/0021-9150(88)90082-2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The effect of CS-514 on serum lipids and apolipoproteins in hypercholesterolemic subjectsPublished by American Medical Association (AMA) ,1987
- The Effect of CS-514, an Inhibitor of HMG-CoA Reductase, on Serum Lipids in Healthy VolunteersAtherosclerosis, 1986
- CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal speciesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Hypocholesterolemic effects of mevinolin in patients with heterozygous familial hypercholesterolemia.Journal of Clinical Investigation, 1984
- Rapid and substantial lowering of human serum cholesterol by mevinolin (MK-803), an inhibitor of hydroxymethylglutaryl-coenzyme a reductaseAtherosclerosis, 1982
- Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemiaEuropean Journal of Clinical Investigation, 1980
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980
- Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemiaAtherosclerosis, 1977
- Competitive inhibition of 3‐hydroxy‐3‐methylglutaryl coenzyme a reductase by ML‐236A and ML‐236B fungal metabolites, having hypocholesterolemic activityFEBS Letters, 1976
- Predisposition to atherosclerosis in the head, heart, and legs. The Framingham studyJAMA, 1972